MitryChem

MitryChem was a French pharmaceutical chemicals company focused on development and production of innovative chemical synthesis processes, custom synthesis, R&D services, and manufacture of active pharmaceutical ingredients and intermediates. The company operated a cGMP-compliant site in Mitry-Mory near Paris with large production units, a pilot plant, a kilo lab, and an R&D team. Public directory and supplier sources describe MitryChem as supplying commercial small-molecule APIs including etodolac and olanzapine and supporting pharma manufacturing under FDA and ANSM-audited standards. However, more recent secondary sources indicate the business entered judicial liquidation, so it does not appear to be an active operating company today.